Matches in Nanopublications for { ?s ?p "[Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP19829.RAkfbZALpZVGgIk66z06WyY3cT24W2cNX2i0r2MD2GpAM130_assertion description "[Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP19829.RAkfbZALpZVGgIk66z06WyY3cT24W2cNX2i0r2MD2GpAM130_provenance.
- NP19824.RAPuW6Gz6W1A-VMR3TFa96rA8goYYdTK97_wsc5N8Oxfw130_assertion description "[Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP19824.RAPuW6Gz6W1A-VMR3TFa96rA8goYYdTK97_wsc5N8Oxfw130_provenance.
- NP19830.RAJ0j3jl4NjE2mnkYDYb3_w9hDrYo9C1l6sKFpfTmd9pc130_assertion description "[Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP19830.RAJ0j3jl4NjE2mnkYDYb3_w9hDrYo9C1l6sKFpfTmd9pc130_provenance.
- NP19110.RASSZ4aPNvjUb-gzdMdOcLNoA8TRJ2VPCdOhucI-xhYzc130_assertion description "[Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP19110.RASSZ4aPNvjUb-gzdMdOcLNoA8TRJ2VPCdOhucI-xhYzc130_provenance.
- NP19104.RA38B9Jlwke-Tl3T_5KyZsw3JxEKduQzuh2tK5Mr2KSnI130_assertion description "[Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP19104.RA38B9Jlwke-Tl3T_5KyZsw3JxEKduQzuh2tK5Mr2KSnI130_provenance.
- NP19111.RAtYRlXoAXvX8STiGSZNabLu5IA6rjeMCU2cmXbb_0VJ8130_assertion description "[Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP19111.RAtYRlXoAXvX8STiGSZNabLu5IA6rjeMCU2cmXbb_0VJ8130_provenance.
- assertion description "[Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP21268.RAYorLlkTrryAk2uEVFx37O8zR508SqOFiNwFSHRBTXq8130_assertion description "[Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21268.RAYorLlkTrryAk2uEVFx37O8zR508SqOFiNwFSHRBTXq8130_provenance.
- NP21269.RASLXF6956gxcriij7OsoI5LI2QAhmf8w_B1dmO3B8S7U130_assertion description "[Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21269.RASLXF6956gxcriij7OsoI5LI2QAhmf8w_B1dmO3B8S7U130_provenance.
- NP21270.RAreOXNLEo3LILXHmC5jCKhTpwjuixTQ--8ik4jYZ-2Vo130_assertion description "[Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21270.RAreOXNLEo3LILXHmC5jCKhTpwjuixTQ--8ik4jYZ-2Vo130_provenance.
- NP21271.RAG8rRY-BL6pcFDm5Ab5sKMlvF2NzuVYFz0pyn5z4ZgOQ130_assertion description "[Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21271.RAG8rRY-BL6pcFDm5Ab5sKMlvF2NzuVYFz0pyn5z4ZgOQ130_provenance.